Skip to main content

Correction: Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer

The Original Article was published on 21 April 2022

Correction: J Exp Clin Cancer Res 41, 151 (2022)

https://doi.org/10.1186/s13046-022-02359-5

Following publication of the original article [1], errors were identified in the Methods and Declarations section. The updated texts re given below and the changes have been highlighted in bold typeface.

Methods

Patient cohort

Patients included in this study were not previously selected, but randomly chosen and recruited between 2014 and 2018.

Declarations

Ethics approval and consent to participate

Signed informed consents were obtained from all patients and healthy volunteers. Twenty-one healthy volunteers have been enrolled on the basis of an experimental protocol approved by the Ethical Committee of the Regina Elena National Cancer Institute (Rome, Italy, ifo_058, IFO_AOO.REGISTRO UFFICIALLE.U.0013925.14-12-2017. Amended on 27-07-2023). Sixty-three patients enrolled between 2014 and 2018 have signed an institutional biobank informed consent. Information about patients was obtained by reviewing their medical charts.

The corrections do not affect the overall result or conclusion of the article. The original article has been corrected.

References

  1. Ronchetti L, Terrenato I, Ferretti M, et al. Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer. J Exp Clin Cancer Res. 2022;41:151. https://doi.org/10.1186/s13046-022-02359-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aymone Gurtner.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s13046-022-02359-5.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ronchetti, L., Terrenato, I., Ferretti, M. et al. Correction: Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer. J Exp Clin Cancer Res 42, 278 (2023). https://doi.org/10.1186/s13046-023-02826-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-023-02826-7